Negative allosteric modulation of the glucagon receptor by RAMP2

Cell. 2023 Mar 30;186(7):1465-1477.e18. doi: 10.1016/j.cell.2023.02.028.

Abstract

Receptor activity-modifying proteins (RAMPs) modulate the activity of many Family B GPCRs. We show that RAMP2 directly interacts with the glucagon receptor (GCGR), a Family B GPCR responsible for blood sugar homeostasis, and broadly inhibits receptor-induced downstream signaling. HDX-MS experiments demonstrate that RAMP2 enhances local flexibility in select locations in and near the receptor extracellular domain (ECD) and in the 6th transmembrane helix, whereas smFRET experiments show that this ECD disorder results in the inhibition of active and intermediate states of the intracellular surface. We determined the cryo-EM structure of the GCGR-Gs complex at 2.9 Å resolution in the presence of RAMP2. RAMP2 apparently does not interact with GCGR in an ordered manner; however, the receptor ECD is indeed largely disordered along with rearrangements of several intracellular hallmarks of activation. Our studies suggest that RAMP2 acts as a negative allosteric modulator of GCGR by enhancing conformational sampling of the ECD.

Keywords: G-protein; G-protein coupled receptor; GPCR; HDX-MS; allostery; cell signaling; cryo-EM; cryo-electron microscopy; glucagon receptor; hydrogen-deuterium exchange monitored by mass spectrometry; protein dynamics; receptor activity-modifying protein RAMP; single molecule fluorescence resonance energy transfer; smFRET.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Cell Membrane / metabolism
  • Glucagon* / metabolism
  • Receptor Activity-Modifying Protein 2 / metabolism
  • Receptors, Glucagon* / metabolism

Substances

  • Glucagon
  • Receptors, Glucagon
  • Receptor Activity-Modifying Protein 2